Provectus Biopharmaceuticals, Inc. Securities Litigation
HomeNotice & Proof of ClaimImportant DatesE-Filing InstructionsCourt DocumentsContact UsFile Claim

Welcome to the Provectus Biopharmaceuticals, Inc. Litigation Website

Provectus Biopharmaceuticals, Inc. Securities Litigation

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF TENNESSEE
KNOXVILLE DIVISION
Case No.:3:14-cv-00338-PLR-HBG

File Claim

IMPORTANT UPDATE TO:

All Persons or Entities who purchased or otherwise acquired the common stock of Provectus Biopharmaceuticals, Inc. (“Provectus”) during the period from December 17, 2013 through and including May 22, 2014, and were allegedly damaged thereby.

The Claims Administrator in this case received a high number of late requests from brokers and other nominees to send notice of this Settlement to potential Settlement Class Members, such that copies of the Postcard Notice were sent to some 6,000 potential Settlement Class Members as late as August 31.  As a result, the Parties to the litigation asked the Court to reschedule the Settlement Hearing and to extend the deadlines for potential Settlement Class Members to: (i) submit a Proof of Claim form; and (ii) request exclusion from the Settlement Class or object to the Settlement, Plan of Allocation, and/or Lead Counsel’s request for attorneys’ fees and expenses. 

On September 29, 2016, the Court entered an order granting the Parties’ request.  According to the Court’s Order:

(i) Proof of Claim forms must be submitted online or postmarked on or before November 25, 2016 in order to be considered for inclusion in the Settlement;

(ii) Requests for Exclusion must be received on or before November 10, 2016; and

(iii) Objections to the Settlement, Plan of Allocation, and/or Lead Counsel’s request for attorneys’ fees and expenses must be received by the Court and counsel on or before November 10, 2016. 

Click here if you wish to submit an online Proof of Claim form.

Additional information concerning how to file a Proof of Claim form, request exclusion from the Settlement Class or object may be found in the Notice.

Finally, please be advised that the Court has rescheduled the Settlement Hearing for December 12, 2016, at 1:30 p.m.  The Settlement Hearing will take place before the Honorable Pamela L. Reeves in Courtroom 3C of the Howard H. Baker, Jr. United States Courthouse, located at 800 Market Street, Knoxville, Tennessee.  You do not have to attend the hearing to be eligible to participate in the Settlement.

Please consult this website for future updates.  

SPECIAL NOTICE TO SECURITIES BROKERS AND OTHER NOMINEES

If you purchased or acquired Provectus common stock during the Class Period for the beneficial interest of an individual or organization other than yourself, the Court has directed that, WITHIN TEN (10) CALENDAR DAYS OF YOUR RECEIPT OF THE POSTCARD NOTICE, you either (a) provide to the Claims Administrator the name and last known address of each person or organization for whom or which you purchased or acquired such securities during such time period or (b) request additional copies of the Postcard Notice and the Proof of Claim form, which will be provided to you free of charge, and within ten (10) days mail the Postcard Notice and Proof of Claim form directly to the beneficial owners of the securities referred to herein. If you choose to follow alternative procedure (b), upon such mailing, you must send a statement to the Claims Administrator confirming that the mailing was made as directed and retain the names and addresses for any future mailings to Class Members. You are entitled to reimbursement from the Settlement Fund of your reasonable expenses actually incurred in connection with the foregoing, including reimbursement of postage expense and the cost of ascertaining the names and addresses of beneficial owners. Your reasonable expenses will be paid upon request and submission of appropriate supporting documentation. All communications concerning the foregoing should be addressed to the Claims Administrator at nominees@ProvectusSecuritiesLitigation.com.